JP2005513036A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005513036A5 JP2005513036A5 JP2003547388A JP2003547388A JP2005513036A5 JP 2005513036 A5 JP2005513036 A5 JP 2005513036A5 JP 2003547388 A JP2003547388 A JP 2003547388A JP 2003547388 A JP2003547388 A JP 2003547388A JP 2005513036 A5 JP2005513036 A5 JP 2005513036A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- overproduction
- iii
- protecting group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 11
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000012261 overproduction Methods 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- XXXJMHLYVRHRNH-IAGOWNOFSA-N ON([C@H](CS(Cc1cc(cccc2)c2nc1)(=O)=O)[C@@H]1OCCC1)C=O Chemical compound ON([C@H](CS(Cc1cc(cccc2)c2nc1)(=O)=O)[C@@H]1OCCC1)C=O XXXJMHLYVRHRNH-IAGOWNOFSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0128378.7A GB0128378D0 (en) | 2001-11-27 | 2001-11-27 | Novel Compounds |
| PCT/EP2002/013264 WO2003045938A1 (en) | 2001-11-27 | 2002-11-25 | Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005513036A JP2005513036A (ja) | 2005-05-12 |
| JP2005513036A5 true JP2005513036A5 (enExample) | 2006-01-05 |
Family
ID=9926525
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003547388A Pending JP2005513036A (ja) | 2001-11-27 | 2002-11-25 | キノリン誘導体、それらの製造方法、ならびにｓ−ＣＤ２３により媒介される障害の治療におけるそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7045626B2 (enExample) |
| EP (1) | EP1448552B1 (enExample) |
| JP (1) | JP2005513036A (enExample) |
| AR (1) | AR037427A1 (enExample) |
| AT (1) | ATE334124T1 (enExample) |
| AU (1) | AU2002365511A1 (enExample) |
| DE (1) | DE60213450T2 (enExample) |
| ES (1) | ES2268133T3 (enExample) |
| GB (1) | GB0128378D0 (enExample) |
| TW (1) | TW200303745A (enExample) |
| WO (1) | WO2003045938A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4505859B2 (ja) | 2003-08-08 | 2010-07-21 | 味の素株式会社 | ナテグリニド含有製剤 |
| AU2012338581B2 (en) | 2011-11-18 | 2016-12-08 | Nxera Pharma Uk Limited | Muscarinic M1 receptor agonists |
| JP6478923B2 (ja) | 2013-02-07 | 2019-03-06 | ヘプタレス セラピューティクス リミテッドＨｅｐｔａｒｅｓ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート |
| GB201404922D0 (en) | 2014-03-19 | 2014-04-30 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201513743D0 (en) | 2015-08-03 | 2015-09-16 | Heptares Therapeutics Ltd | Muscarinic agonists |
| GB201519352D0 (en) | 2015-11-02 | 2015-12-16 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201617454D0 (en) | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819961D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB202020191D0 (en) | 2020-12-18 | 2021-02-03 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1001930T3 (da) * | 1997-07-31 | 2003-03-24 | Abbott Lab | N-hydroxyformamidderivater som inhibitorer af matrix-metalloproteinaser |
| HUP0100597A3 (en) | 1998-01-30 | 2001-12-28 | Darwin Discovery Ltd Cambridge | Hydroxamic and carboxylic acid derivatives |
-
2001
- 2001-11-27 GB GBGB0128378.7A patent/GB0128378D0/en not_active Ceased
-
2002
- 2002-11-25 DE DE60213450T patent/DE60213450T2/de not_active Expired - Lifetime
- 2002-11-25 TW TW091134147A patent/TW200303745A/zh unknown
- 2002-11-25 EP EP02790436A patent/EP1448552B1/en not_active Expired - Lifetime
- 2002-11-25 AR ARP020104526A patent/AR037427A1/es not_active Application Discontinuation
- 2002-11-25 US US10/496,193 patent/US7045626B2/en not_active Expired - Fee Related
- 2002-11-25 AT AT02790436T patent/ATE334124T1/de not_active IP Right Cessation
- 2002-11-25 JP JP2003547388A patent/JP2005513036A/ja active Pending
- 2002-11-25 WO PCT/EP2002/013264 patent/WO2003045938A1/en not_active Ceased
- 2002-11-25 ES ES02790436T patent/ES2268133T3/es not_active Expired - Lifetime
- 2002-11-25 AU AU2002365511A patent/AU2002365511A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005500357A5 (enExample) | ||
| IL160028A (en) | Thiophene carboxamide derivatives, process for their preparation, pharmaceutical compositions comprising them and their use in therapy | |
| JP2004534850A5 (enExample) | ||
| JP2007514005A5 (enExample) | ||
| JP2009502743A5 (enExample) | ||
| JP2003503454A5 (enExample) | ||
| BR0008979A (pt) | Composto quìmico, uso de um composto, método de tratamento, processo de preparação de um composto, composição farmacêutica e método de fabricação da mesma | |
| AP1782A (en) | Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus. | |
| JP2003522198A5 (enExample) | ||
| EP2039686A4 (en) | DIHYDROPYRIMIDIN COMPOUNDS AND THEIR USES IN THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT AND PREVENTION OF ANTIVIRAL DISEASES | |
| MXPA04003245A (es) | Hidroxipropilaminas. | |
| JP2002509153A5 (enExample) | ||
| JP2002510633A5 (enExample) | ||
| JP2005513036A5 (enExample) | ||
| JP2008513510A5 (enExample) | ||
| JPH09188680A5 (enExample) | ||
| JP2002522501A5 (enExample) | ||
| IL150817A0 (en) | Pyrrole-type compounds, compositions, and methods for treating cancer or viral diseases | |
| JP2010500284A5 (enExample) | ||
| JP2006508124A5 (enExample) | ||
| JP2005501108A5 (enExample) | ||
| JP2005513034A5 (enExample) | ||
| RU2004112422A (ru) | Роувастатин в преддеменционных состояниях | |
| AU2002362008A1 (en) | Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease | |
| ATE447953T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis |